Get Assistance
Modern Treatments
Ayurveda Treatments
Best Doctors In India

Dr. Hari Goyal

Consult Dr. Hari Goyal
Gurugram (Delhi NCR)
Languages Spoken
Dr. Hari Goyal

About Dr. Hari Goyal

Dr. Hari Goyal’s Qualifications

M.B.B.S. – Sardar Patel Medical College, Bikaner, 1993
M.D. (Internal Medicine) – SMS Medical college, Jaipur, 1997
D.M. (Medical Oncology) – AIIMS, New Delhi, 2003
PDCR (Professional Dioploma in Clinical Research) – 2008

Dr. Hari Goyal’s Previous Experience/Employment

Tata Memorial hospital : 6 months
Rajiv Gandhi Cancer Institute : 1 year
AIIMS ,Delhi : 3 years and 6 months.
Batra hospital , New delhil: 3 years
B.L Kapoor Hospital, New delhi :2 years
Action Cancer Hospital ,New delhi : 6 years

Dr. Hari Goyal’s Speciality

Dr. Hari Goyal’s Research and Publications

1. Unusual neurological syndrome of hyperkplexia. Rajasthan, 1993
2. Acute carbon monoxide poisoning leading to myocardial injury, motor ataxia, Journal of association physicians on india. 45: 408:1997.
3. Brain stem infarct : unusual neurological complication of cerebral malaria Journal of association physicians on india. 45: 408:1997
4. Electrocardiographic diagnosis of acute left BBB : Current medical trends : 1997 :1: 111-112.
5. Primary extranodal non-hodgkins lymphoma in northern india : Proc Am Soc clin oncol.: 22: 611: 2003.
6. Testicular germ cell tumors: experience from a single centre in india: Proc Am Soc clin oncol :22: 422: 2003.
7. Imatinib mesylate in treatment of CML : Proc Am Soc clin oncol: 22: 221: 2003.
8. Oxaliplatin and folinic acid and 5-FU : A first line therapy in colorectal cancer: Oncology: 2002.
9. Long term outcome of hairy cell leukemia: experience from a IRCH. AIIMS.Oncology hematology . 2003.
10. Interferon induced lupus nephritis in patients of CML: March 2005 : 46:481-482.

Poster presentation
Novel and effective management of capecitabine induced hand foot syndrome : Proc Am Soc clin oncol: 23:751: 2004(Abstract 8105)

Research Activities
1. Clinical research associate in protocol 94CE 32 .Phase III comparative study of combination treatment with TLC D99 liposomal doxorubicin and cyclophosphamide and doxorubicin in metastatic breast cancer.
2. A Multicentric ,open label phase III clinical trial to evaluate the safety of filgrastim in cancer patients with grade 3 or 4 chemotherapy induced neutropenia.
3. Organizing secretary, 4th international seminar on psycosocial oncology, new delhi, april 1999.

Works At Hospital
Aster Hospitals
Hospital's Accreditation
HBG Medical Assistance Copyright © 2021 All Rights Reserved
magnifiercrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram